Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25465650 | 0.93 | KDM4E (0.43) | KDM4EHPGDCYP19A1MAPTSMN1; SMN2 | |
| SCHEMBL23319971 | 0.92 | ALOX15 (0.42) | KDM4EHPGDMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL22816619 | 0.89 | KDM4E (0.42) | KDM4EHPGDCYP19A1MAPTSMN1; SMN2 | |
| SCHEMBL26467810 | 0.88 | CYP19A1 (0.39) | KDM4EHPGDCYP19A1MAPTSMN1; SMN2 | |
| SCHEMBL22816596 | 0.87 | ALOX15 (0.42) | KDM4EHPGDMAPTALDH1A1POLB | |
| SCHEMBL22815996 | 0.86 | KDM4E (0.45) | KDM4EHPGDCYP19A1MAPTSMN1; SMN2 | |
| SCHEMBL26088232 | 0.86 | S1PR4 (0.40) | KDM4EHPGDMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL25465647 | 0.85 | ALOX15 (0.41) | KDM4EHPGDMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL22816248 | 0.85 | ALDH1A1 (0.45) | KDM4EHPGDCYP19A1MAPTSMN1; SMN2 | |
| SCHEMBL26467681 | 0.84 | CYP19A1 (0.39) | KDM4ECYP19A1MAPTPOLBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024215907-A1 | CRYSTALLINE FORMS OF A 1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID COMPOUND | Cantero Therapeutics, Inc. (US) | 2024-10-17 | — | — | WO | disclosed |
| WO-2024212137-A1 | CRYSTALLINE FORMS OF A 1H-1, 2, 3-TRIAZOLE-4-CARBOXYLIC ACID COMPOUND | Cantero Therapeutics, Inc. (US) | 2024-10-17 | — | — | WO | disclosed |
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | PHOENIX TISSUE REPAIR, INC. | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143491-A1 | TRIAZOLE GLYCOLATE OXIDASE INHIBITORS | XDH, DUOX1, PNPO | KDM4E 3502/4885HPGD 116/4885CYP19A1 1521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.